Zhidong Wang - Publications

Affiliations: 
2018-2022 Peking University, Beijing, Beijing Shi, China 

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Liu D, Qi X, Wei X, Zhao L, Wang X, Li S, Wang Z, Shi L, Xu J, Hong M, Liu Z, Zhao L, Wang X, Zhang B, Zhang Y, et al. A Novel Her2/VEGFR2/CD3 trispecific antibody with an optimal structural design showed improved T-cell-redirecting antitumor efficacy. Theranostics. 12: 7788-7803. PMID 36451856 DOI: 10.7150/thno.75037  0.536
2022 Guo H, Wang M, Wang B, Guo L, Cheng Y, Wang Z, Sun YQ, Wang Y, Chang YJ, Huang XJ. PRDM1 Drives Human Primary T Cell Hyporesponsiveness by Altering the T Cell Transcriptome and Epigenome. Frontiers in Immunology. 13: 879501. PMID 35572579 DOI: 10.3389/fimmu.2022.879501  0.34
2021 Cao YJ, Wang X, Wang Z, Zhao L, Li S, Zhang Z, Wei X, Yun H, Choi SH, Liu Z, Zhao L, Kazane SA. Switchable CAR-T Cells Outperformed Traditional Antibody-Redirected Therapeutics Targeting Breast Cancers. Acs Synthetic Biology. PMID 33856201 DOI: 10.1021/acssynbio.1c00007  0.546
2020 Wang Z, Cao YJ. Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research. Frontiers in Immunology. 11: 176. PMID 32194541 DOI: 10.3389/Fimmu.2020.00176  0.5
Show low-probability matches.